Critical heart drug too pricey for some Medicare patients

An effective drug to treat chronic heart failure may cost too much for senior citizens with a standard Medicare Part D drug plan, said a study co-authored by a John A. Burns School of Medicine (JABSOM) researcher at the University of Hawaii at Manoa.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/critical-heart-drug-too-pricey-for-some-medicare-patients